Correlation Between Technology Portfolio and Fidelity Advisor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Technology Portfolio and Fidelity Advisor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Technology Portfolio and Fidelity Advisor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Technology Portfolio Technology and Fidelity Advisor Health, you can compare the effects of market volatilities on Technology Portfolio and Fidelity Advisor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Technology Portfolio with a short position of Fidelity Advisor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Technology Portfolio and Fidelity Advisor.

Diversification Opportunities for Technology Portfolio and Fidelity Advisor

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Technology and Fidelity is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Technology Portfolio Technolog and Fidelity Advisor Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Advisor Health and Technology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Technology Portfolio Technology are associated (or correlated) with Fidelity Advisor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Advisor Health has no effect on the direction of Technology Portfolio i.e., Technology Portfolio and Fidelity Advisor go up and down completely randomly.

Pair Corralation between Technology Portfolio and Fidelity Advisor

Assuming the 90 days horizon Technology Portfolio Technology is expected to generate 1.69 times more return on investment than Fidelity Advisor. However, Technology Portfolio is 1.69 times more volatile than Fidelity Advisor Health. It trades about 0.11 of its potential returns per unit of risk. Fidelity Advisor Health is currently generating about 0.11 per unit of risk. If you would invest  2,618  in Technology Portfolio Technology on September 6, 2024 and sell it today you would earn a total of  1,306  from holding Technology Portfolio Technology or generate 49.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Technology Portfolio Technolog  vs.  Fidelity Advisor Health

 Performance 
       Timeline  
Technology Portfolio 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Technology Portfolio Technology are ranked lower than 19 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Technology Portfolio showed solid returns over the last few months and may actually be approaching a breakup point.
Fidelity Advisor Health 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity Advisor Health are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Fidelity Advisor is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Technology Portfolio and Fidelity Advisor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Technology Portfolio and Fidelity Advisor

The main advantage of trading using opposite Technology Portfolio and Fidelity Advisor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Technology Portfolio position performs unexpectedly, Fidelity Advisor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Advisor will offset losses from the drop in Fidelity Advisor's long position.
The idea behind Technology Portfolio Technology and Fidelity Advisor Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bonds Directory
Find actively traded corporate debentures issued by US companies